We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current IDNA market cap is 125.15M. The company's latest EPS is USD 0.9846 and P/E is 22.47.
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | |||||
| Operating Income | |||||
| Net Income |
| Year End 31 July 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 451k | 1.54M | 2.26M | 1.42M | 1.46M |
| Operating Income | 0 | 0 | 0 | 0 | 0 |
| Net Income | 14.99M | 53.88M | -134.66M | -48.88M | 5.56M |
| Quarter End | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | |||||
| Total Liabilities | |||||
| Total Equity |
| Year End 31 July 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 155.4M | 342.22M | 228.96M | 169.13M | 153.48M |
| Total Liabilities | 13.72M | 14.41M | 29.62M | 24.13M | 13.07M |
| Total Equity | 141.68M | 327.82M | 199.33M | 144.99M | 140.41M |
| Market Cap | 125.15M |
| Price to Earnings Ratio | 22.47 |
| Price to Sales Ratio | 85.9 |
| Price to Cash Ratio | 867.45 |
| Price to Book Ratio | 0.89 |
| Dividend Yield | - |
| Shares Outstanding | 5.65M |
| Average Volume (1 week) | 37.6k |
| Average Volume (1 Month) | 30.58k |
| 52 Week Change | -3.02% |
| 52 Week High | 25.80 |
| 52 Week Low | 21.52 |
| Spread (Intraday) | 3.22 (13.29%) |
| Company Name | iShares Genomics Immunology and Healthcare ETF |
| Address |
100 summer street boston, massachusetts 02110 |
| Website | https://www.ishares.com |
| Industry | mgmt invt offices, open-end (6722) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
